Literature DB >> 12684867

LRIG1 protein in human cells and tissues.

Jonas Nilsson1, Anna Starefeldt, Roger Henriksson, Håkan Hedman.   

Abstract

We have recently cloned the human LRIG1 gene (formerly LIG1). LRIG1 is a predicted integral cell-surface protein showing similarities to Kekkon-1, the Drosophila melanogaster epidermal growth-factor-receptor antagonist. A specific peptide antibody, LRIG1-151, was raised in rabbits and used to study the LRIG1 protein. LRIG1 migrated in denaturing polyacrylamide gel electrophoresis under reducing conditions as two species with apparent molecular weights of 143 kDa and 134 kDa, and as two fragments corresponding to an N-terminal 111-kDa species and a C-terminal 32-kDa species. Under non-reducing conditions, both apparent monomers and apparent higher molecular weight complexes were evident. Immunoblotting analysis of cell-surface-biotinylated lysates and confocal microscopy revealed that LRIG1 was localized to the cell surface in ZR-75 cells expressing endogenous LRIG1 and in COS-7 cells expressing a synthetic LRIG1-GFP fusion protein. Immunohistochemical analysis of normal human tissues showed staining for LRIG1 in epithelia in various organs, scattered neurons, and muscles. Immunoblotting demonstrated LRIG1 protein in tissue lysates from normal human prostate, mammary epithelial cells, ileum, stomach, lung, and cerebral cortex. These results demonstrate that LRIG1 is an integral cell-surface membrane protein that is expressed by specific cells in various human tissues and that its 143-kDa form might be cleaved into 111-kDa and 32-kDa fragments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684867     DOI: 10.1007/s00441-003-0697-1

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  30 in total

1.  Effects of RNAi-mediated gene silencing of LRIG3 expression on cell cycle and survival of glioma cells.

Authors:  Mingjun Cai; Ruifan Xie; Lin Han; Rudong Chen; Baofeng Wang; Fei Ye; Dongsheng Guo; Ting Lei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

2.  Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence.

Authors:  Kim B Jensen; Fiona M Watt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-28       Impact factor: 11.205

3.  Effect of silencing LRIG3 gene on the proliferation and apoptosis of bladder cancer T24 cells.

Authors:  Xiaoyi Yuan; Shixin Bao; Weimin Yang; Zhangqun Ye
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-04-20

4.  Lrig1 is a cell-intrinsic modulator of hippocampal dendrite complexity and BDNF signaling.

Authors:  Fernando Cruz Alsina; Francisco Javier Hita; Paula Aldana Fontanet; Dolores Irala; Håkan Hedman; Fernanda Ledda; Gustavo Paratcha
Journal:  EMBO Rep       Date:  2016-03-02       Impact factor: 8.807

5.  Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.

Authors:  Soma Ghasimi; Hannu Haapasalo; Mine Eray; Katariina Korhonen; Thomas Brännström; Håkan Hedman; Ulrika Andersson
Journal:  J Neurooncol       Date:  2012-04-08       Impact factor: 4.130

6.  Using a new Lrig1 reporter mouse to assess differences between two Lrig1 antibodies in the intestine.

Authors:  Emily J Poulin; Anne E Powell; Yang Wang; Yina Li; Jeffrey L Franklin; Robert J Coffey
Journal:  Stem Cell Res       Date:  2014-09-20       Impact factor: 2.020

Review 7.  ErbB receptor negative regulatory mechanisms: implications in cancer.

Authors:  Colleen Sweeney; Jamie K Miller; David L Shattuck; Kermit L Carraway
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

Review 8.  Mechanisms of ErbB receptor negative regulation and relevance in cancer.

Authors:  William H D Fry; Lakmal Kotelawala; Colleen Sweeney; Kermit L Carraway
Journal:  Exp Cell Res       Date:  2008-07-31       Impact factor: 3.905

9.  LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.

Authors:  Gal Gur; Chanan Rubin; Menachem Katz; Ido Amit; Ami Citri; Jonas Nilsson; Ninette Amariglio; Roger Henriksson; Gideon Rechavi; Håkan Hedman; Ron Wides; Yosef Yarden
Journal:  EMBO J       Date:  2004-07-29       Impact factor: 11.598

10.  Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3).

Authors:  Hanine Rafidi; Francisco Mercado; Michael Astudillo; William H D Fry; Matthew Saldana; Kermit L Carraway; Colleen Sweeney
Journal:  J Biol Chem       Date:  2013-05-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.